Skip to main content
. 2016 Oct 31;6:36177. doi: 10.1038/srep36177

Table 5. The clinicopathological characteristics of the male MPLC patients.

  19del + L858R 19del + WT L858R L858R + WT WT
Age
 <30 0.00% 0.00% 0.00% 0.00% 0.00%
 <40 0.00% 0.00% 0.00% 0.00% 0.00%
 <50 20.00% 33.33% 0.00% 0.00% 12.50%
 <60 20.00% 33.33% 40.00% 57.14% 25.00%
 <70 40.00% 33.33% 40.00% 42.86% 37.50%
 <80 0.00% 0.00% 10.00% 0.00% 25.00%
 >80 20.00% 0.00% 10.00% 0.00% 0.00%
Site
 Left 60.00% 33.33% 35.00% 42.86% 50.00%
 Right 40.00% 66.67% 65.00% 57.14% 50.00%
Pathology
 Lung adenocarcinoma 90.00% 66.67% 95.00% 85.71% 81.25%
 Squamous carcinoma 10.00% 0.00% 0.00% 0.00% 15.63%
 Large cell carcinoma 0.00% 0.00% 0.00% 7.14% 3.13%
 Atypical hyperplasia of adenoma 0.00% 33.33% 5.00% 7.14% 0.00%
TNM stage
 Tis 0.00% 0.00% 5.00% 14.29% 9.38%
 Ia 70.00% 16.67% 60.00% 50.00% 53.13%
 Ib 30.00% 83.33% 25.00% 35.71% 34.38%
 IIb 0.00% 0.00% 0.00% 0.00% 3.13%
 IIIa 0.00% 0.00% 10.00% 0.00% 0.00%